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Assay conditions for chondroitin sulfotransferase in serum were established using a rapid and simple paper 
disk method. Sulfotransferase activities towards endogenous serum glycosaminoglycans d exogenously 
added chondroitin were determined for fetal, newborn and adult bovine sera. The results indicate that 3’- 
phosphoadenosine S-phosphosulfate (PAPS); chondroitin 6-sulfotransferase ctivity in fetal calf serum is 
several times that in newborn or adult bovine sera. The enzyme transfers sulfate onto position 6 of internal 
nonsulfated galactosamine units of endogenous and exogenous chondroitin. 
Sulfation Chondroitin sulfate Sulfotransferase 
1. INTRODUCTION 
Defective sulfation of chondroitin sulfate results 
in growth defect [1,2]. Enhanced degradation of 
sulfate donor, PAPS, causes undersulfation of 
chondroitin sulfate in Lowe’s syndrome and the 
patients exhibit severe pathological conditions [3]. 
These observations suggest he biological impor- 
tance of the sulfation of glycosaminoglycans 
(GAGS) and other macromolecules. Biosynthetic 
mechanisms of sulfation of macromolecules in- 
cluding GAGS have only been poorly understood. 
In the course of the investigation of sulfation reac- 
tions in various mammalian tissues, it was found 
that a considerable amount of 35S radioactivity is in- 
corporated into chondroitinase-sensitive materials 
Abbreviations: Hepes, 4-(2-hydroxyethyl)-l-piperazine- 
ethane sulfonic acid; Mes, 2-(N-morpholino)ethanesul- 
fonic acid; ADi-OS, 2-acetamide-2-deoxy-3-O-(&D- 
gluco-4-enepyranosyluronic acid)-D-galactose; ADi-4S, 
2-acetamido-2-deoxy-3-O-~-D-gluco-4-enepyranosyl- 
uranic acid)-4-0-sulfo-D-galactose; ADi-6S, 2-aceta- 
mido-2-deoxy-3-O-(&(3-D-gluco-4-enepyranosyluronic 
acid)-6-0-sulfo-D-galactose 
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upon incubation of fetal calf serum (FCS) with 35S- 
labeled PAPS. [3’S]Sulfate incorporation was 
markedly higher with FCS than with adult bovine 
serum. This paper reports the elevated chondroitin 
6-sulfotransferase activity found in FCS. 
2. MATERIALS AND METHODS 
2.1. Materials 
[3SS]PAPS (2.2 Ci/mmol) was purchased from 
New England Nuclear. Nonradioactive PAPS was 
from Sigma. 2,3-Dimercaptopropan-l-01 (DMP) 
was obtained from Wako, Osaka, Japan. Pronase 
P was from Kaken Kagaku, Tokyo. Chondroitin- 
ase AC, ADi-OS, ADi-4S, ADi-6S, and GAG 
preparations were from Seikagaku Kogyo, Tokyo. 
Fetal and newborn calf sera, and horse serum were 
obtained from Gibco. Adult bovine and human 
sera were prepared from fresh blood supplied by a 
local slaughterhouse and donated by volunteers, 
respectively. 
2.2. Methods 
The paper disk method developed for the assay 
of serum glycosyltransferases [4] was applied to 
the sulfotransferase assays. This method is advan- 
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tageous for multiple assays over the trichloroacetic 
acid precipitation/centrifugation or paper chroma- 
tographic methods (51. The standard incubation 
conditions were determined so as to maximize the 
total [35S]sulfate incorporation into acid-insoluble 
endogenous acceptors using FCS. The Zn’+-specif- 
ic chelator DMP [6] as well as EDTA were utilized 
to protect PAPS from enzymatic breakdown. The 
pH optimum was in the range of 7-8. The apparent 
Km for PAPS was 7.4 PM. The following two 
methods were thus established epending upon the 
sulfate acceptors. Dilution of sera was made with 
buffer I (IO mM Hepes-NaOH, pH 7.4) if 
necessary. 
Assay 1 was designed to determine the sulfo- 
transferase activities towards both endogenous ac- 
ceptors and heated FCS added exogenously. Each 
incubation mixture contained 20~1(8OO~g protein) 
serum, 10 ~1 buffer II (see below), 10~1 of 60pM 
[35S]PAPS (3-8 x 10’ cpm), and 20~1 buffer I (for 
the assay without exogenous acceptors) or 20 ~1 
(800 ag protein) of heated FCS which had been 
treated at 56°C for 3 h. The heat treatment com- 
pletely abolished the sulfotransferase activities of 
FCS. Buffer II contained 30 mM EDTA, 60 mM 
MgCl2, 30 mM DMP in 60 mM Hepes-NaOH, pH 
7.4. Following incubation at 37°C for 30-90 min, 
incorporation of [35S]sulfate into acceptors was 
determined by the paper disk method. Aliquots of 
the reaction mixture were spotted onto paper 
disks, which were sequentially washed in 10% 
trichloroacetic acid, ethanol/ether (2 : 1, v/v) and 
ether as reported [4], and counted in a liquid scin- 
tillation counter. 
Assay 2 was designed to determine the sulfo- 
transferase activities towards exogenously added 
chondroitin. The incubation mixture contained 20 
~1 (40 fig protein) serum, 10 ,& buffer II, 10 pl of 
60 FM [3*S]PAPS (l-3 x lo5 cpm), and 20 ,~l of 6 
mg/ml chondroitin. The Km for chondroitin 
(sodium salt) was 0.17 mglml. Determination of 
transfer of [35S]sulfate to exogenous chondroitin 
was made in a modified paper disk method where 
washing of the paper disks was carried out in n- 
butyric acid/O.5 M ammonia (5 : 3, v/v) (solvent I) 
instead of 10070 trichloroacetic acid. Sulfate trans- 
fer to exogenous chondroitin was proportional to 
the amount of serum protein and to the incubation 
period until approx. 20% of PAPS was consumed. 
isolation of GAGS labeled with [35S]sulfate were 
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carried out as follows. FCS was incubated over- 
night as in Assays 1 and 2 with [35S]PAPS (3.2 x 
IO6 cpm) and then GAGS were isoiated. The assay 
1 incubation mixture was treated with 0.5 M 
NaOH at 4°C for 18 h, neutralized with 1 M HCl, 
and digested with pronase [7]. Following 5% 
trichloroacetic acid treatment of the pronase 
digest, the trichloroacetic acid-soluble fraction was 
treated with ether to extract trichloroacetic acid, 
mixed with carrier GAGS and chromatographed on 
a column (1 .O x 56 cm) of Sephadex G-50 fine with 
0.05 M pyridine-acetate buffer (pH 5.3) as reported 
[7]. The excluded fractions containing GAGS 
(3.98x IO5 cpm) were evaporated to dryness and 
digested with chondroitinase as described [7]. The 
assay 2 incubation mixture was treated with 5% 
trichloroacetic acid. The trichloroacetic acid- 
soluble fraction was chromatographed on Sephadex 
G-50 as above. The excluded fractions containing 
GAGS (2.02 x lo6 cpm) were isolated and sub- 
jected to chondroitinase digestion. The trichloro- 
acetic acid-insoluble fraction contained a negligi- 
ble amount of labeled GAGS. Exogenous chon- 
droitin inhibited sulfate incorporation into en- 
dogenous acceptors by 90%. 
Radioactivity was determined by liquid scintilIa- 
tion counting. Protein was determined by the 
method of Lowry et al. [8]. 
3. RESULTS AND DISCUSSION 
Upon incubation of FCS with [35S]PAPS under 
the established conditions, sulfate incorporation 
into endogenous acceptors was proportional to the 
incubation period and to the amount of serum pro- 
tein in the range of 600-12OOpg. With less than 600 
pg of protein the linearity was not obtained, 
presumably because the concentrations of en- 
dogenous acceptors and/or other endogenous re- 
quirements were too low. In the appropriate range 
of protein concentration, [35S]sulfate transfer to 
endogenous acceptors was determined for various 
sera. The results indicate that FCS has severa 
times the activity of sera from newborn calves or 
adult animals (fig.1). Although most of the serum 
samples were supplied in a frozen state, adult 
bovine sera and human sera were prepared from 
fresh blood. Upon repeated freeze-thawing no loss 
of activity of FCS was observed. Thus, the lower 
activity of sulfate transfer in sera from newborn or 
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Fig.1. Sulfotransferase activities in various sera. The 
assays were carried out as described in section 2. Open, 
hatched, and solid columns indicate activities with 
endogenous acceptors, exogenous heated FCS and 
exogenous chondroitin, respectively. Each column and 
each vertical bar represent he mean and the standard 
deviation, respectively. The left ordinate shows the 
activities with endogenous acceptors and heated FCS 
while the right ordinate shows those with chondroitin. 
FCS, fetal calf serum; NCS, newborn calf serum; BS, 
adult bovine serum; HoS, adult horse serum; HuS, adult 
human serum. Eight FCS, 4 NCS, 3 BS, 1 HoS, and 3 
HuS samples were assayed. 
adult animals is not due to inactivation of sulfo- 
transferases or acceptors during storage. 
In the next experiments each incubation was car- 
ried out with heated FCS exogenously added. In its 
presence [35S]sulfate incorporation into an acid- 
insoluble fraction was proportional to the amount 
of serum protein tested and to the incubation 
period. Under these conditions FCS still showed 
higher activities than sera from newborn calves or 
adult animals (fig.l), suggesting that the higher 
sulfate incorporation observed with FCS was at- 
tributed to higher sulfotransferase activities rather 
than higher concentrations of endogenous accep- 
tors or activators. 
Characterization of the endogenous 35S-labeled 
products obtained from the incubation of FCS 
with [‘%]PAPS indicated that 93% of the “S- 
labeled macromolecules was sensitive to chon- 
droitinase AC and that 77 and 11% of the pro- 
duced radioactive oligosaccharides were ADi-6S 
and ADi4S, respectively. These results indicate 
that the higher incorporation of sulfate with FCS 
is due most likely to a higher enzymatic activity of 
the sulfotransferase which catalyzes sulfate trans- 
fer onto the 6 position of internal nonsulfated 
galactosamine residues of endogenous chondroitin 
(or chondroitin sulfate) proteoglycans. The sulfo- 
transferase assay was then carried out with ex- 
ogenous chondroitin as a sulfate acceptor. As 
shown in fig.1, with chondroitin as an acceptor 
each serum showed 30-100-fold the sulfotrans- 
ferase activity detected with heated FCS (note the 
scale). The results confirmed the substantial dif- 
ference in the sulfotransferase activity between 
FCS and sera from newborn or adult animals. 
Sulfated products obtained from the incubation of 
FCS with [3sS]-PAPS and exogenous chondroitin 
were analyzed. 35S-labeled products were 
recovered by extraction with 5% trichloroacetic 
acid followed by gel filtration on Sephadex G-50. 
Under the conditions used 65% of the 35S radioac- 
tivity added to the reaction was found in this frac- 
tion (see section 2). The isolated radioactive 
material was completely digested by chondroitin- 
ase AC as judged by gel filtration (not shown). 
Upon paper chromatography of the oligosac- 
charide fraction 96 and 3% of the radioactivity 
were recovered in ADi-6S and ADi-4S, respectively 
(fig.%). No detectable oversulfated disaccharide 
was observed. These results indicate that the 
observed sulfate transfer measured with exogenous 
chondroitin as an acceptor was also predominantly 
5 10 15 
Distance from Ortgm(cm) 
Fig.2. Descending paper chromatography of the 
chondroitinase digest. Isolation of 35S-labeled GAGS 
and preparation of the chondroitinase AC digest were 
described in section 2. An aliquot of the oligosaccharide 
fraction (9700 cpm) was mixed with 0.2 pmol each of 
ADi-4S and ADi-6S, and chromatographed on Toyo 
NoSlA paper in solvent I for 36 h. The carrier 
disaccharides were localized under the UV-lamp. For 
determination of radioactivity the paper was cut into 1 
cm-wide strips and counted in a liquid scintillation 
counter. 
45 
Volume 183, number 1 FEBS LETTERS April 1985 
onto position 6 of internal nonsulfated galactos- 
amine units of chondroitin, and that the 
6-sulfotransferase activity is indeed higher in FCS 
than in sera from newborn or adult animals. 
Proteoglycans or GAGS are thought to be in- 
volved in morphogenesis and development of 
many tissues [9]. Developmental changes in chon- 
droitin sulfate isomers have been reported for 
some tissues on the basis of GAG analyses. 
However, alterations of sulfotransferase activities 
supporting such changes have not been reported. 
Rather it has been indicated that degree of sulfa- 
tion can be regulated in some instances by the 
availability of PAPS [1,3,10] or by the environ- 
mental sulfate concentrations [ 111. The present 
studies demonstrate levated chondroitin 6-sulfo- 
transferase activity in fetal calf serum, which may 
reflect developmentally controlled biosynthesis of 
chondroitin sulfate in some unlocated tissue. Pre- 
dominant serum GAGS are low sulfated or fully 
sulfated chondroitin 4-sulfate, and chondroitin 
6-sulfate, if any, is only a minor component [12]. 
It is unlikely that the 6-sulfotransferase functions 
in blood since the PAPS level therein is below the 
limit of detection. Rather it possibly functions in 
the cell or tissue from which it originates. It is of 
interest o investigate the origin of the enzyme and 
a possibility of elevation of the enzyme activity 
with oncogenesis. 
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